EVOK News Alert Evoke Pharma Inc (EVOK) 5.45 12/16/2014 23:3

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Evoke Pharma Inc (EVOK) 5.45 $EVOK

Nasdaq stocks posting largest percentage decreases
AP - Tue Dec 02, 5:04PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
EVOK: 5.45 (+0.02), CTCM: 4.66 (+0.11), RDCM: 10.68 (-0.15), MCEP: 6.16 (+0.66), QDEL: 25.33 (+0.22), POZN: 9.03 (+0.10), AREX: 4.68 (+0.11)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Dec 02, 11:47AM CST

CY: 13.98 (+0.13), QDEL: 25.33 (+0.22), WLT: 1.57 (-0.09), VNCE: 26.77 (-0.69), ISNS: 2.36 (-0.09), VII: 1.34 (-0.05), NTLS: 4.29 (+0.23), MFRM: 56.28 (-3.46), GSAT: 2.69 (-0.01), MOLG: 2.49 (-0.15), EVOK: 5.45 (+0.02), IDRA: 3.59 (+0.13), SCVL: 25.84 (+0.76), VGGL: 3.43 (+0.28), MIXT: 6.36 (+0.17), ENVI: 1.29 (-0.02), REI: 8.32 (+0.14), TRX: 0.60 (-0.11), DGLY: 14.38 (+0.34), CODE: 32.34 (+0.34)

Evoke clears another hurdle on its path to NDA for metoclopramide nasal spray
Seeking Alpha - at Seeking Alpha - Tue Dec 02, 8:05AM CST

EVOK: 5.45 (+0.02)

Evoke Pharma's EVK-001 Showed No QT Prolongation in Thorough ECG (TQT) Study
GlobeNewswire - Tue Dec 02, 7:30AM CST
Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced results from an electrocardiogram (ECG) study that assessed the potential of metoclopramide nasal spray (EVK-001) to increase the cardiac QT and corrected QT (QTc) interval across a range of plasma concentrations. The study was conducted to satisfy a safety requirement by the U.S. Food and Drug Administration (FDA) in support of the submission of a New Drug Application (NDA) for EVK-001, an investigational medication for relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. The study met the pre-specified primary endpoint, demonstrating that EVK-001, at therapeutic and supratherapeutic doses, did not prolong the QT/QTc interval in healthy subjects.
EVOK: 5.45 (+0.02)

Evoke Pharma to Present at LD Micro Conference
GlobeNewswire - Tue Nov 25, 7:31AM CST
Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, will host an investor presentation on Thursday, December 4, 2014 at 11:30AM PT at the LD Micro Main Event VII Conference. The conference is being held December 2-4, 2014 at the Luxe Sunset Boulevard Hotel in Los Angeles, California.
EVOK: 5.45 (+0.02)

Dr. Kenneth J. Widder Joins Quidel's Board of Directors
Marketwired - Wed Nov 19, 3:39PM CST
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Kenneth J. Widder, M.D. has agreed to join Quidel's Board of Directors, effective immediately. Quidel's Board has been expanded to eight members.
EVOK: 5.45 (+0.02), QDEL: 25.33 (+0.22)

Supernus Pharmaceuticals (SUPN) in Focus: Stock Up 9.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 19, 8:32AM CST
Supernus Pharmaceuticals, Inc. (SUPN) was a big mover last session, as the company saw its shares nearly 10% on the day.
EVOK: 5.45 (+0.02), AKRX: 37.55 (-2.17), SUPN: 8.72 (+0.08)

Evoke Pharma's (EVOK) CEO Dave Gonyer on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 13, 8:04PM CST

EVOK: 5.45 (+0.02)

Evoke Pharma beats by $0.15
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 3:10PM CST

EVOK: 5.45 (+0.02)

Evoke Pharma Reports Third Quarter 2014 Results
GlobeNewswire - Thu Nov 13, 3:09PM CST
Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced its financial results for the third quarter ended September 30, 2014.
EVOK: 5.45 (+0.02)

Evoke Pharma Schedules Webcast and Conference Call for Third Quarter 2014 Financial Results
GlobeNewswire - Thu Nov 06, 7:42AM CST
Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that it will issue its financial results for the Third Quarter of 2014 on Thursday, November 13, 2014, after the close of the market.
EVOK: 5.45 (+0.02)

Evoke Pharma completes enrollment of ECG Study of EVK-001 for diabetic gastroparesis ahead of schedule
M2 - Wed Sep 10, 6:22AM CDT
Pharmaceutical company Evoke Pharma (NasdaqCM:EVOK) disclosed on Tuesday that it has completed the enrollment in its thorough ECG (electrocardiogram) (QT) study of its lead product candidate EVK-001.
EVOK: 5.45 (+0.02)

Evoke Pharma Announces the Completion of Enrollment in Its Thorough ECG Study for EVK-001
GlobeNewswire - Tue Sep 09, 7:30AM CDT
Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that it has completed enrollment in its thorough ECG (QT) study of EVK-001, the Company's lead product candidate. EVK-001 is currently in a Phase 3 clinical trial for the relief of symptoms associated with acute and recurrent gastroparesis in women with diabetes mellitus.
EVOK: 5.45 (+0.02)

Evoke Pharma to Present at the Aegis Capital Corp. 2014 Healthcare & Technology Conference
GlobeNewswire - Thu Sep 04, 7:35AM CDT
Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that Dave Gonyer, CEO, will present a corporate overview at the Aegis Capital Corp. 2014 Healthcare & Technology Conference, being held September 10-13, 2014 at The Encore at The Wynn in Las Vegas, Nevada. The Company is scheduled to present on Thursday, September 11, 2014 at 2:00pm PT. A copy of the corporate overview will be posted to the company's website following the presentation.
EVOK: 5.45 (+0.02)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

AlphaPoint's Approval Device Targets AI Attack Risk

Updated Category News Views 13

A Separate Screen May Be Worth More Than Another Patch AlphaPoint is taking a fairly old security instinct and aiming it at a very current headache: if the laptop is lying to the employee, do not let the laptop have the final say. Its newly introduced Approval Device is dedicated hardware with its own display, built to let authorized staff inspect and approve sensitive...

Continue Reading
AltaPointe PATH Outreach Puts Housing Waits in Focus

Updated Category News Views 128

Two years is a brutal length of time to ask somebody without stable housing to wait for an income-based apartment. That number hangs over AltaPointe Health's PATH program in Mobile, Alabama, and it ought to. The organization helped 16 people secure permanent housing in the past fiscal year, a figure that can look small if somebody is just skimming a report. It looks very...

Continue Reading
New York's $1.2M Prison Abuse Deal Raises State Stakes

Updated Category News Views 41

One courtroom result can expose a whole warehouse of institutional neglect, and this one lands with a grim thud. New York has agreed to pay $1.2 million to resolve a claim involving sexual assault by a former corrections officer at Bayview Correctional Facility in Manhattan. The settlement came after a two-week Adult Survivors Act bellwether trial concluded on November 17...

Continue Reading
Why Professional Collaboration May Matter More in AI

Updated Category News Views 51

Three smart professionals can still hand a client a mess when nobody owns the handoff. That unglamorous reality sits behind the Professional Collaboration Institute, or PCI, which Sarano and Brooke Kelley plan to launch in a virtual briefing on December 2. The outfit wants to turn cross-profession coordination into a teachable, measurable discipline rather than leave it...

Continue Reading
Oman’s Dhofar II Wind Deal Clears Financing Hurdle

Updated Category News Views 111

Dhofar’s next wind farm has crossed the line that matters: financial close. That is less glamorous than turbines spinning against an Omani skyline, but it is the point where a project stops being an attractive deck and becomes a real contractual obligation. Sembcorp Utilities, alongside OQ Alternative Energy through Naseem Dhofar SAOC, has brought the 125-megawatt...

Continue Reading
AI Shopping Answers Are Becoming Retail's New Shelf

Updated Category News Views 46

Retail’s front door is quietly being moved by a machine, and plenty of big chains appear to be staring at the old entrance. Bain’s latest work lands on an uncomfortable point: owning market share does not guarantee a retailer gets named when an AI assistant answers a shopper’s question. That ought to rattle management teams more than the usual holiday-season...

Continue Reading
FCC Opens Prison Jamming Door, Raising Execution Stakes

Updated Category News Views 81

A Regulatory Door Finally Moves Five hundred thousand contraband phones is the sort of estimate that makes a rule change hard to shrug off. On November 19, 2026, the Federal Communications Commission adopted its Third Report and Order in GN Docket No. 13-111, allowing RF jamming in state and local correctional facilities for the first time. That is a meaningful break from...

Continue Reading
First Grade Literacy Push Deserves a Harder Look Now

Updated Category News Views 146

A reading gap can become a concrete wall before anyone bothers measuring it. That is the uncomfortable point behind Ignite Reading's First Grade Promise, and it deserves more attention than another polished education announcement usually gets. At a Nov. 5 Convene 2026 gathering in Boston, 56 district and literacy leaders from six states focused on getting children reading...

Continue Reading
Fervo’s 46% Slide Puts Geothermal Claims Under Fire

Updated Category News Views 162

A 46% haircut from an IPO price has a way of stripping the paint off a growth story. Fervo Energy closed at $14.33 after the October 6 report cited in Hagens Berman’s announcement, well below its $27 IPO price from last May. That does not prove the report is right. It does mean NASDAQ:FRVO investors are staring at questions that go straight to the economic spine of...

Continue Reading
Hydron’s Bailey Test Puts RNG Cost Claims to Real Work

Updated Category News Views 55

Landfill gas is messy stuff, which is exactly why Hydron Energy’s Bailey Landfill demonstration in Chilliwack deserves more attention than another clean-energy press release. The British Columbia company is putting its INTRUPTor™ gas-separation system into an operating environment alongside FortisBC and the City of Chilliwack, where the machinery has to deal with real...

Continue Reading

Top 5 Most Recently Viewed Articles

Champion of Change Award Boosts Educational Futures

Updated Category News Views 24

Changing the Odds: Paramount Unified's New Honor The education world isn't all about books and grades anymore. It's about inspiring passions and igniting possibilities. That's what Think Together is up to with Paramount Unified School District—a partnership that's earned the latter the 2026 Champion of Change Award. And boy, have they earned it. The Foundation of Trust...

Continue Reading
Allegiant Overhauls Service with UNLV Training

Updated Category News Views 213

Allegiant Airlines and UNLV: A Unique Collaboration The world of airline customer service is about to get a shakeup, thanks to a new collaboration between Allegiant Airlines and the University of Nevada, Las Vegas' renowned William F. Harrah College of Hospitality. It's a partnership that aims to bring a new level of service to the skies, guided by some of the best minds...

Continue Reading
Royal LePage Benchmark and Virtuo: A New Era in Real Estate

Updated Category News Views 166

Transforming Real Estate: Royal LePage Benchmark and Virtuo Partnership This exciting partnership marks a significant step forward for one of Alberta's most prominent brokerages, Royal LePage Benchmark, as it teams up with Virtuo, a leader in AI technology. This collaboration aims to empower agents by enhancing their ability to offer seamless and personalized experiences...

Continue Reading
Frazil Soars in Recognition Among Top Utah Companies

Updated Category News Views 216

Frazil Recognized Among Top Companies Frazil, the award-winning frozen beverage company, has recently made headlines as one of the fastest-growing companies within the state. This recognition speaks volumes about the dedication and commitment to excellence that Frazil embodies in its operations and products. Growth and Innovation Frazil's inclusion on the prestigious...

Continue Reading
Celebrating Legal Excellence: James Scott Farrin Attorneys Honored

Updated Category News Views 96

Acknowledgment of Legal Expertise The Law Offices of James Scott Farrin continuously demonstrate a strong commitment to legal excellence, evidenced by the recent recognition of three of their outstanding attorneys in the 'Super Lawyers' 2025 listing. This accolade reaffirms the firm’s dedication to premier legal representation in personal injury law, and highlights the...

Continue Reading